NL-OMON31650已完成2 期
A Multicenter, Open Label, Randomized Study of AMG 951 in Subjects with Previously Untreated Stage IIIb/IV Non-Small Cell Lung Cancer (NSCLC) Treated with Chemotherapy with or without Bevacizumab - not applicable
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- Amgen
- 入组人数
- 19
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •· Histologically or cytologically confirmed Non-Small Cell Lung Cancer
- •· Subjects must have advanced NSCLC stage IIIb or Stage IV disease.
- •. Planning to receive at least 6 cycles of therapy
- •· ECOG performance status of 0 or 1
- •· Life expectancy greater than 3 months
- •· ³18 years old
- •· INR £ 1.2 and PTT is no greater than ULN within 1 week prior to
排除标准
- •· Prior malignancy other than NSCLC (except in situ basal cell carcinoma or
- •in situ cervical cancer), unless have been treated with curative intent
- •with no evidence of disease for ³ 3 years
- •· Myocardial infarction, or unstable or uncontrolled disease or condition
- •related to or impacting cardiac function within 1
- •year of enrollment
- •· Uncontrolled hypertension
- •· History of arterial thrombosis, pulmonary embolus within 1 year of
- •· Recent major surgical procedure within 28 days of enrollment
- •· Subjects must not have serious non-healing wound ulcer, or bone
- •fracture within 21 days prior to enrollment
- •. Prior chemotherapy
研究者
相似试验
进行中（未招募）
不适用
A Multicenter, Open Label, Randomized Study of AMG 951 in Subjects with Previously Untreated Stage IIIb/IV Non-Small Cell Lung Cancer (NSCLC) Treated with Chemotherapy with or without Bevacizumab - 20050190Treatment of patients with stage IIIb/IV non-small cell lung cancerMedDRA version: 14.1Level: PTClassification code 10029522Term: Non-small cell lung cancer stage IVSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 14.1Level: PTClassification code 10029521Term: Non-small cell lung cancer stage IIIBSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2005-005484-28-ITAmgen Inc.224
进行中（未招募）
不适用
A Multicenter, Open Label, Randomized Study of AMG 951 in Subjects with Previously Untreated Stage IIIb/IV Non-Small Cell Lung Cancer (NSCLC) Treated with Chemotherapy with or without BevacizumabSubjects with Previously Untreated Stage IIIb/IV Non-Small Cell Lung Cancer (NSCLC) Treated with Chemotherapy with or without BevacizumabMedDRA version: 9.1Level: LLTClassification code 10029522Term: Non-small cell lung cancer stage IVMedDRA version: 9.1Level: LLTClassification code 10029521Term: Non-small cell lung cancer stage IIIBEUCTR2005-005484-28-PLAmgen Inc.200
进行中（未招募）
1 期
A Multicenter, Open Label, Randomized Study of AMG 951 in Subjects with Previously Untreated Stage IIIb/IV Non-Small Cell Lung Cancer (NSCLC) Treated with Chemotherapy with or without BevacizumabSubjects with Previously Untreated Stage IIIb/IV Non-Small Cell Lung Cancer (NSCLC) Treated with Chemotherapy with or without BevacizumabMedDRA version: 8.1 Level: LLT Classification code 10029521 Term: Non-small cell lung cancer stage IIIBMedDRA version: 9.1 Level: LLT Classification code 10029522 Term: Non-small cell lung cancer stage IVEUCTR2005-005484-28-GBAmgen Inc.224
进行中（未招募）
1 期
A Multicenter, Open Label, Randomized Study of AMG 951 in Subjects with Previously Untreated Stage IIIb/IV Non-Small Cell Lung Cancer (NSCLC) Treated with Chemotherapy with or without BevacizumabSubjects with Previously Untreated Stage IIIb/IV Non-Small Cell Lung Cancer (NSCLC) Treated with Chemotherapy with or without BevacizumabMedDRA version: 8.1Level: LLTClassification code 10029521Term: Non-small cell lung cancer stage IIIBMedDRA version: 9.1Level: LLTClassification code 10029522Term: Non-small cell lung cancer stage IVEUCTR2005-005484-28-SKAmgen Inc.224
进行中（未招募）
不适用
A Multicenter, Open Label, Randomized Study of AMG 951 in Subjects with Previously Untreated Stage IIIb/IV Non-Small Cell Lung Cancer (NSCLC) Treated with Chemotherapy with or without BevacizumabSubjects with Previously Untreated Stage IIIb/IV Non-Small Cell Lung Cancer (NSCLC) Treated with Chemotherapy with or without BevacizumabMedDRA version: 8.1Level: LLTClassification code 10029521Term: Non-small cell lung cancer stage IIIBMedDRA version: 9.1Level: LLTClassification code 10029522Term: Non-small cell lung cancer stage IVEUCTR2005-005484-28-BEAmgen Inc.224